• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Talkiatry Lands $20M to Expand In-Network Psychiatric Care

by Jasmine Pennic 07/28/2021 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Talkiatry Lands $20M to Expand In-Network Psychiatric Care

What You Should Know:

– Talkiatry, a leading provider of in-network psychiatric care today announced it raised $20 million as completion of its Series A funding. The round includes an additional $15 million, led by Left Lane Capital with further participation from Dr. Richard Park, founder and former CEO of CityMD. In February 2021, Talkiatry kicked off its Series A round after raising $5 million led by Sikwoo Capital Partners with participation from Relevance Ventures and Dr. Park.

– The funding will enable Talkiatry to further develop its proprietary technology and expand operations into additional states in the Northeast as well as the Mid-Atlantic and South regions in 2022. Talkiatry currently employs over 30 psychiatrists and over 40 total providers and has logged over 30,000 patient visits since its launch. Talkiatry is partnered with all of the nation’s leading health insurers, including United Health Care, Aetna, Humana, Cigna, and Blue Cross Blue Shield. With a hybrid model of in-person and virtual care, Talkiatry is increasing access of the highest quality, responsibly.

Why It Matters

The pandemic has exacerbated the already broken mental healthcare system. 1 in 5 adults are living with mental illness and sadly 60% of them go untreated every year due to a shortage of qualified providers or expensive out-of-pocket costs.  Founded in 2020, Talkiatry is increasing the accessibility of high quality and responsible psychiatric care throughout the United States. With tailored support solutions and proprietary technology, Talkiatry’s team of psychiatrists are enabled to achieve insights into their patient populations that were previously unattainable. From pre-diagnosing patients to tracking their progress over time, Talkiatry’s insights and high quality care reduces the overall healthcare costs for their insurance partners and in turn, patients and employers.

“Talkiatry is built by psychiatrists, for psychiatrists and we are uniquely situated to understand and address the access, cost and quality issues plaguing outpatient behavioral healthcare,” said Robert Krayn, Co-Founder and CEO of Talkiatry. “With the completion of our Series A, we will expand our offering to states with a desperate need for responsible, affordable, and high quality care.” 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Behavioral Health

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |